Regent Investment Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-16,085
Closed -$134K 196
2022
Q2
$134K Sell
16,085
-1,000
-6% -$14K 0.04% 189
2022
Q1
$390K Buy
17,085
+2,000
+13% +$48.9K 0.09% 155
2021
Q4
$416K Buy
15,085
+325
+2% +$8.7K 0.09% 158
2021
Q3
$411K Sell
14,760
-885
-6% -$25.1K 0.1% 160
2021
Q2
$459K Hold
15,645
0.11% 151
2021
Q1
$497K Sell
15,645
-8,650
-36% -$254K 0.13% 132
2020
Q4
$505K Sell
24,295
-6,000
-20% -$112K 0.14% 120
2020
Q3
$471K Sell
30,295
-1,800
-6% -$31K 0.15% 120
2020
Q2
$587K Buy
32,095
+8,600
+37% +$152K 0.2% 103
2020
Q1
$364K Buy
+23,495
New +$567K 0.15% 118

Other funds holding BHC

Regent Investment Management's BHC Position: Q3 2022 in Review

Regent Investment Management sold out of Bausch Health (BHC) in Q3 2022, closing a stake of 16,085 shares — an estimated $134K sold.

Regent Investment Management first reported a position in BHC in Q1 2020 and held it in 10 quarters. The position peaked at $587K in Q2 2020. 283 funds tracked by Wall St. Rank hold BHC as of Q3 2022.

  • Regent Investment Management reported no remaining Bausch Health position as of Q3 2022 after selling out during the quarter.
  • Regent Investment Management sold 16,085 Bausch Health shares in Q3 2022, an estimated $134K.
  • Regent Investment Management first reported a position in Bausch Health in Q1 2020 and held it in 10 quarters.
  • Regent Investment Management's Bausch Health position peaked at $587K in Q2 2020.
  • 283 funds tracked by Wall St. Rank held Bausch Health as of Q3 2022.

Based on Regent Investment Management's 13F filing for Q3 2022, filed 18 Oct 2022.